SEGMENT AND ENTERPRISE-WIDE INFORMATION

We determine our reportable segments by first identifying our operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Our operating segments are based primarily on geography. North America Plasma is a separate operating segment with dedicated segment management due the size and scale of the Plasma business unit. We aggregate components within an operating segment that have similar economic characteristics.

The Company’s reportable segments are as follows:


•	Japan


•	EMEA


•	North America Plasma


•	All Other

The Company has aggregated the Americas Blood Center and Hospital and Asia - Pacific operating segments into the All Other reportable segment based upon their similar operational and economic characteristics, including similarity of operating margin.

Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and turnaround costs, deal amortization, asset impairments, accelerated depreciation and certain legal charges. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company's net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.

During the first quarter of fiscal 2019, management reorganized its operating segments such that certain immaterial components of EMEA are now reported as components of All Other. Accordingly, the prior year numbers have been updated to reflect this reclassification as well as other changes within the cost reporting structure that occurred in the first quarter of fiscal 2019. These changes did not have an impact on our ability to aggregate Americas Blood Center and Hospital with Asia - Pacific.

Selected information by business segment is presented below:



	Three Months Ended
(In thousands)	June 30, 2018		July 1, 2017
Net revenues
Japan	$	16,604	$	15,232
EMEA	41,288		40,439
North America Plasma	91,574		77,536
All Other	79,812		80,743
Net revenues before foreign exchange impact	229,278		213,950
Effect of exchange rates	69		(2,999		)
Net revenues	$	229,347	$	210,951



	Three Months Ended
(In thousands)	June 30, 2018			July 1, 2017
Segment operating income
Japan	$	8,267		$	7,467
EMEA	12,040			10,498
North America Plasma	38,596			27,200
All Other	33,041			30,671
Segment operating income	91,944			75,836
Corporate operating expenses	(54,273		)	(48,050		)
Effect of exchange rates	3,055			(2,201		)
Restructuring and turnaround costs	(3,349		)	(2,483		)
Deal amortization	(6,300		)	(6,491		)
Asset impairments	(21,170		)	—
Accelerated depreciation	(3,939		)	—
Legal charges	(675		)	—
Operating income	$	5,293		$	16,611

Our products are organized into three categories for purposes of evaluating their growth potential: Plasma, Blood Center and Hospital. Management reviews revenue trends based on these business units; however, no other financial information is currently available on this basis.

Net revenues by business unit are as follows:



	Three Months Ended
(In thousands)	June 30, 2018		July 1, 2017
Plasma	$	116,903	$	101,507
Blood Center	64,483		65,565
Hospital	47,961		43,879
Net revenues	$	229,347	$	210,951

Net revenues generated in our principle operating regions on a reported basis are as follows:



	Three Months Ended
(In thousands)	June 30, 2018		July 1, 2017
United States	$	142,140	$	131,052
Japan	17,389		14,916
Europe	39,002		37,222
Asia	29,395		25,940
Other	1,421		1,821
Net revenues	$	229,347	$	210,951